About Zabit Pharmaceutical
Zabit Pharmaceutical was a Healthcare company based in London (United Kingdom) founded in 2011. It develops innovative devices for platelet functioning tests. It operates on a B2B model. The company is recorded as dissolved. Its focus areas include Medical Devices, Diagnostics and Blood Testing. Its competitors include Accumetrics, AggreDYNE, COC Pharmaceuticals Industry, ThrombusCheck and DCM Pharmaceutical Industry; 2 of its 5 listed competitors have raised funding.
Company details
Zabit Pharmaceutical develops innovative devices for platelet functioning tests through providing healthcare solutions, developing medical devices, offering diagnostic solutions, and blood testing. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters London, United Kingdom
- SectorsHealthcare
- Website zabitpharmaceutical.com
Competitors of Zabit Pharmaceutical
Zabit Pharmaceutical has 5 listed competitors in our database, 2 of them funded. They include Accumetrics, AggreDYNE, COC Pharmaceuticals Industry, ThrombusCheck and DCM Pharmaceutical Industry, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| accumetrics.com | 1996 | San Diego, United States | $97.53M | 46 | Platelet function assays and coagulation systems are developed and marketed. | |
| aggredyne.com | 2011 | Houston, United States | $3M | – | Platelet stickiness is measured using patented Aggreguide A-100. | |
| cocpharmaceuticals.com | 2011 | Glasgow, United Kingdom | – | – | Develops diagnostic devices for platelet function analysis. | |
| thrombuscheck.com | 2017 | Palo Alto, United States | – | – | Offers a device that mimics plaqued arteries for personalized anti-platelet therapy. | |
| dcmpharmaceutical.com | 2011 | London, United Kingdom | – | – | Creates innovative diagnostic devices for measuring platelet dysfunction in healthcare. |
Detailed competitors of Zabit Pharmaceutical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Hematology
10 companies that operate in the same segment as Zabit Pharmaceutical (Hematology), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Catheter-based thrombectomy devices for vascular emboli removal are developed. | 2011 | Irvine, California, United States | USD 51.89 M | USD 493.63 M | 696 | |
Small activating RNA therapeutics are developed to restore gene function. | 2008 | London, England, United Kingdom | USD 460.41 M | USD 23.07 M | 37 | |
Small molecules are developed to treat hematologic and musculoskeletal disorders. | 2016 | Lexington, Kentucky, United States | USD 90 M | USD 244.06 M | 169 | |
Developer of Allogeneic cell therapy for cancer, autoimmune diseases and genetic blood disorders | 2016 | Menlo Park, California, United States | USD 300 M | – | 384 | |
Developer of therapeutics for the treatment of hematologic diseases | 2017 | Cambridge, Massachusetts, United States | USD 140 M | – | 84 | |
Gene therapy platform is developed for chronic disease treatments. | 2015 | Stevenage, Hertfordshire, United Kingdom | USD 273.69 M | USD 435.87 K | 152 | |
Novel anticoagulants for thrombosis treatment are developed. | 2019 | Cambridge, Massachusetts, United States | USD 250 M | – | 13 | |
Developer of therapies for treating hemochromatosis & beta thalassemia | 1989 | San Diego, California, United States | – | USD 75.72 M | 71 | |
Breakthrough therapies are developed for blood diseases and infections. | 2014 | Buffalo, New York, United States | USD 1 M | – | 22 | |
Hematology products and solutions are provided for medical applications. | 1971 | Braintree, Massachusetts, United States | – | USD 1.33 B | 3,020 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Zabit Pharmaceutical
Zabit Pharmaceutical was founded in 2011.
Zabit Pharmaceutical is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Zabit Pharmaceutical develops innovative devices for platelet functioning tests through providing healthcare solutions, developing medical devices, offering diagnostic solutions, and blood testing. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Zabit Pharmaceutical's top competitors include Accumetrics, AggreDYNE and COC Pharmaceuticals Industry.